Search Within

Department of Medicine

Formats
  1. Journal Article (19618)
  2. Meeting Abstract (16046)
  3. Review (1158)
  4. Book Section (934)
  5. Editorial (611)
  6. Research Letter (316)
  7. Conference Paper (301)
  8. Guidelines (298)
  9. Correspondence (236)
  10. Miscellaneous (90)
  11. Book Whole (61)
Groups
  1. Solid Tumor Oncology Division (22348)
  2. Hematologic Malignancies, Division of (13287)
  3. Center for Hematologic Malignancies (11069)
  4. GSK Faculty (10653)
  5. Survivorship Research (9346)
  6. Division of Subspecialty Medicine (7554)

More Groups

People
  1. Robert Motzer (1249)
  2. Howard Scher (1133)
  3. Sergio Giralt (1069)
  4. Miguel-Angel Perales (943)
  5. Clifford Hudis (906)
  6. Jedd Wolchok (905)

More People

Years
  1. 2025 (1118)
  2. 2024 (2291)
  3. 2023 (2452)
  4. 2022 (2621)
  5. 2021 (2534)
  6. 2020 (2563)

More Years

Publications
  1. Journal of Clinical Oncology (6125)
  2. Blood (3722)
  3. Annals of Oncology (1398)
  4. Cancer Research (1238)
  5. Clinical Cancer Research (902)
  6. Biology of Blood and Marrow Transplantation (679)

More Publications

Publishers
  1. American Society of Clinical Oncology (6458)
  2. Elsevier Inc. (4216)
  3. American Society of Hematology (4003)
  4. American Association for Cancer Research (2896)
  5. Oxford University Press (2291)
  6. Nature Publishing Group (2121)

More Publishers

Results (39669)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • EGFR and KRAS mutational analysis of mucinous pneumonic bronchiololavelolar carcinomas
    Meeting Abstract

    Zakowski, M.; Ladanyi, M.; Kris, M.; Rusch, V.; Pao, W.
    Lung Cancer (2005)

    Fulltext@MSK | Save
  • In vitro expansion of antigen-specific cytotoxic T lymphocytes by HLA-A*0201 transfected K562 for monitoring of T-cell responses
    Meeting Abstract

    Yuan, J.; Gallardo, H. F.; Rasalan, T.; Ranganathan, R.; Wang, J.; Zhang, Y.; Stan, R.; Young, J. W.; Houghton, A. N.; Wolchok, J. D.
    Journal of Immunotherapy (2005)

    Fulltext@MSK | Save
  • Results of a phase 2 trial of HGS-ETR1 (Agonistic human monoclonal antibody to TRAIL receptor 1) in subjects with relapsed/refractory non-Hodgkin's lymphoma (NHL)
    Meeting Abstract

    Younes, A.; Vose, J. M.; Zelenetz, A. D.; Smith, M. R.; Burris, H.; Ansell, S.; Klein, J.; Kumm, E.; Czuczman, M.
    Blood (2005)

    Fulltext@MSK | Save
  • Specificity of NKT cells against GD3 ganglioside
    Meeting Abstract

    Wu, D. Y.; Chapman, P. B.
    Clinical Immunology (2005)

    Fulltext@MSK | Save
  • Quality of life with malignant bowel obstruction: Provider assessed health state utilities
    Meeting Abstract

    Wong, S. L.; Wong, D.; Elkin, E. B.
    Journal of Clinical Oncology (2005)

    Fulltext@MSK | Save
  • Phase II study of dose-adjusted EPOCH-R in untreated de novo CD20+ diffuse large B-cell lymphoma (DLBCL)-CALGB 50103
    Meeting Abstract

    Wilson, W. H.; Porcu, P.; Hurd, D.; Martin, S. E.; Czuczman, M.; Niedzwiecki, D.; Saint Louis, J. D.; Johnson, J. L.; Cheson, B.; Canellos, G. P.; more...
    Journal of Clinical Oncology (2005)

    Fulltext@MSK | Save
  • Melanoma patients with positive sentinel nodes who do not undergo completion lymphadenectomy: A multi-institutional study
    Meeting Abstract

    Wong, S. L.; Thompson, J. F.; Gershenwald, J. E.; Leong, S. P.; Reintgen, D. S.; Sabel, M. S.; Gutman, H.; McMasters, K. M.; Tyler, D. S.; Coit, D. G.
    Annals of Surgical Oncology (2005)

    Fulltext@MSK | Save
  • Combination chemotherapy regimens with pentostatin in patients with chronic lymphocytic leukemia and other low grade lymphoid neoplasms
    Meeting Abstract

    Weiss, M. A.; Kalaycio, M.; Zelenetz, A. D.; Lamanna, N.
    Annals of Oncology (2005)

    Fulltext@MSK | Save
  • Cost-effectiveness of hepatic artery infusion for metastatic colorectal cancer (CALGB 9481)
    Meeting Abstract

    Weeks, J. C.; Romanus, D.; Herndon, J. E.; Schrag, D.; Mayer, R. J.; Kemeny, N.
    Value in Health (2005)

    Fulltext@MSK | Save
  • A randomized trial of cytarabine with high-dose mitoxantrone compared to a standard vincristine/prednisone-based regimen as induction therapy for adult patients with ALL
    Meeting Abstract

    Weiss, M. A.; Heffner, L.; Lamanna, N.; Kalaycio, M.; Schiller, G.; Coutre, S.; Maslak, P.; Jurcic, J.; Panageas, K.; Scheinberg, D. A.
    Journal of Clinical Oncology (2005)

    Fulltext@MSK | Save